MedTrace Logo

Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants

NCT00480948 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2011-06-07

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the efficacy of infant formula having proportion of palmitate in the sn-2 position comparable to human milk in Chinese term infants.

Conditions

  • Healthy

Interventions

BEHAVIORAL

Infant formula feeding (InFat™)

Infant formula with InFat™ oil (containing \~49% of C16:0 at sn-2 position), 24 wk

DIETARY_SUPPLEMENT

Control

Standard vegetable oil based infant formula

Sponsors & Collaborators

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Yi Xiang Su, MD Professor · Sun Yat-sen University

  • Yuming Chen, PhD · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-04-30
Completion
2009-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00480948 on ClinicalTrials.gov